Literature DB >> 26187767

Non-immunospecific association of immunoglobulin G with chromatin during elution from protein A inflates host contamination, aggregate content, and antibody loss.

Pete Gagnon1, Rui Nian2, Yuansheng Yang2, Qiaohui Yang2, Chiew Ling Lim2.   

Abstract

Monoclonal IgG at pH 3.5 expressed a tendency to self-associate and associate non-specifically with surfaces, including the surfaces of precipitated chromatin heteroaggregates. The tendency was elevated with protein A-eluted IgG still in elution buffer (100mM acetate, pH 3.5). Association of IgG with chromatin elements under protein A elution conditions amplified host protein contamination of the elution fraction about 15-fold, caused formation of aggregates that persisted after pH neutralization, and imposed an approximate 5% loss on IgG recovery. Neutralization released eluted IgG from its low pH associations with chromatin and caused heteroaggregate remnants to associate into large particles easily removed by microfiltration. Most effective host contaminant clearance was achieved by filtration after neutralization to pH 5.5. All chromatin-mediated liabilities were suspended by extraction of chromatin heteroaggregates in advance of protein A.
Copyright © 2015 The Authors. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Aggregation; Chromatin; Host contamination; IgG; Protein A; Recovery

Mesh:

Substances:

Year:  2015        PMID: 26187767     DOI: 10.1016/j.chroma.2015.07.017

Source DB:  PubMed          Journal:  J Chromatogr A        ISSN: 0021-9673            Impact factor:   4.759


  2 in total

1.  Application of enhanced electronegative multimodal chromatography as the primary capture step for immunoglobulin G purification.

Authors:  Yanli Wang; Quan Chen; Mo Xian; Rui Nian; Fei Xu
Journal:  AMB Express       Date:  2018-06-01       Impact factor: 3.298

2.  Mild hypothermic culture conditions affect residual host cell protein composition post-Protein A chromatography.

Authors:  Cher Hui Goey; David Bell; Cleo Kontoravdi
Journal:  MAbs       Date:  2018-02-16       Impact factor: 5.857

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.